Joincare Pharmaceutical Group IndustryLtd Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Xiong Yu
Chief executive officer
CN¥3.6m
Total compensation
CEO salary percentage | 72.2% |
CEO tenure | no data |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | no data |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | CN¥1b |
Dec 31 2023 | CN¥4m | CN¥3m | CN¥1b |
Sep 30 2023 | n/a | n/a | CN¥1b |
Jun 30 2023 | n/a | n/a | CN¥2b |
Mar 31 2023 | n/a | n/a | CN¥2b |
Dec 31 2022 | CN¥4m | CN¥3m | CN¥2b |
Sep 30 2022 | n/a | n/a | CN¥1b |
Jun 30 2022 | n/a | n/a | CN¥1b |
Mar 31 2022 | n/a | n/a | CN¥1b |
Dec 31 2021 | CN¥3m | CN¥2m | CN¥1b |
Compensation vs Market: Xiong's total compensation ($USD497.37K) is above average for companies of similar size in the CN market ($USD211.10K).
Compensation vs Earnings: Xiong's compensation has been consistent with company performance over the past year.
CEO
Xiong Yu (62 yo)
no data
Tenure
CN¥3,600,000
Compensation
Mr. Xiong Yu serves as Non-Executive Director of Livzon Pharmaceutical Group Inc. since June 30, 2020. He serves as the Deputy Vice-President and a Researcher of China State Institute of Pharmaceutical Ind...